Insider Transactions in Q2 2023 at Arcellx, Inc. (ACLX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Indirect |
28
+24.78%
|
-
|
|
Jun 01
2023
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Direct |
113
+25.0%
|
-
|
|
Jun 01
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
25,556
-1.02%
|
$1,124,464
$44.35 P/Share
|
|
May 31
2023
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
2,600
-6.71%
|
$114,400
$44.27 P/Share
|
|
May 31
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
315,164
-11.14%
|
$12,921,724
$41.5 P/Share
|
|
May 25
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-38.75%
|
$252,000
$42.77 P/Share
|
|
May 24
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,704
-18.16%
|
$365,568
$42.06 P/Share
|
|
May 23
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,428
+48.11%
|
-
|
|
May 11
2023
|
Sr One Capital Management, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,012,833
-9.23%
|
$45,577,485
$45.58 P/Share
|
|
May 11
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
638,417
-9.23%
|
$28,728,765
$45.58 P/Share
|
|
May 10
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,197
-21.99%
|
$98,865
$45.18 P/Share
|
|
May 09
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
500
-4.77%
|
$22,500
$45.0 P/Share
|
|
May 05
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,200
-10.26%
|
$54,000
$45.0 P/Share
|
|
May 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-10.46%
|
$129,000
$43.14 P/Share
|
|
May 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+16.96%
|
$45,000
$15.0 P/Share
|
|
Apr 24
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-63.11%
|
$800,000
$40.0 P/Share
|
|
Apr 24
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+27.77%
|
$200,000
$10.64 P/Share
|
|
Apr 19
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,642
-57.23%
|
$547,470
$35.01 P/Share
|
|
Apr 19
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,345
+19.58%
|
$123,450
$10.64 P/Share
|
|
Apr 18
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-28.59%
|
$210,000
$35.0 P/Share
|
|
Apr 18
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+12.08%
|
$54,000
$10.64 P/Share
|
|
Apr 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-8.24%
|
$90,000
$30.9 P/Share
|
|
Apr 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+13.9%
|
$45,000
$15.0 P/Share
|